<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The anti-leukaemic effect of low-dose <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> was assessed in 36 patients; 15 patients presented with an <z:hpo ids='HP_0011009'>acute</z:hpo> myeloblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and were treated in first induction because of age or preexisting disease and clinical and biological stabilization was obtained in 7 cases, with a mean duration of 8.7 months </plain></SENT>
<SENT sid="1" pm="."><plain>In 4 relapsed patients 2 complete remissions were obtained, 1 of which after several courses of <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases an important haematopoietic and extra-haematopoietic toxicity was noticed </plain></SENT>
<SENT sid="3" pm="."><plain>In 15 patients treated for a <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> terminating in <z:hpo ids='HP_0011009'>acute</z:hpo> myeloblastic <z:mpath ids='MPATH_336'>leukaemia</z:mpath> stabilization was obtained in 8 cases, but final conclusions were difficult </plain></SENT>
<SENT sid="4" pm="."><plain>The cytotoxic effect of <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> even at low dosage remains important </plain></SENT>
<SENT sid="5" pm="."><plain>The optimal modalities in the administration, and the actual advantages of this treatment compared with conventional chemotherapy have still to be defined </plain></SENT>
</text></document>